Echo IQ Ltd
Company Profile
Business description
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care. Geographically, the company operates in Australia and United States, majority from Australian markets.
Contact
66 Clarence Street
Level 11
SydneyNSW2000
AUST: +61 894268999
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
Employees
Stocks News & Analysis
stocks
An undervalued stock to buy that even Warren Buffett likes
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,841.20 | 55.80 | -0.63% |
| CAC 40 | 8,081.43 | 41.98 | -0.52% |
| DAX 40 | 25,266.53 | 144.10 | -0.57% |
| Dow JONES (US) | 51,349.98 | 161.61 | -0.31% |
| FTSE 100 | 10,679.99 | 25.27 | -0.24% |
| HKSE | 24,333.52 | 427.61 | -1.73% |
| NASDAQ | 26,939.37 | 3.34 | 0.01% |
| Nikkei 225 | 66,318.14 | 804.15 | 1.23% |
| NZX 50 Index | 13,805.35 | 19.48 | -0.14% |
| S&P 500 | 7,704.13 | 1.90 | -0.02% |
| S&P/ASX 200 | 8,658.10 | 43.90 | -0.50% |
| SSE Composite Index | 3,888.37 | 48.15 | -1.22% |